Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters

Publication year range
1.
Ther Adv Respir Dis ; 17: 17534666221148660, 2023.
Article in English | MEDLINE | ID: mdl-36800913

ABSTRACT

BACKGROUND AND OBJECTIVE: The global prevalence and incidence of nontuberculous mycobacterial (NTM) infections are increasing; however, population-level data on healthcare use and medical costs for people with NTM infections are limited. Thus, we investigated the rates of healthcare use and medical costs of people with NTM infections in South Korea using the National Health Insurance Service-National Sample Cohort from 2002 to 2015. METHODS: In this cohort study, people with and without NTM infection aged 20-89 years were matched 1 to 4 by sex, age, Charlson comorbidity index, and year of diagnosis. The overall and annual average healthcare use and medical costs were calculated. In addition, trends in healthcare use and medical costs for each of the 3 years before and after NTM diagnosis were investigated for people diagnosed with NTM infection. RESULTS: A total of 798 individuals (336 men and 462 women) diagnosed with NTM infection and 3192 controls were included in the study. NTM-infected patients had significantly higher rates of healthcare use and medical costs than those in the control group (p < 0.05). NTM-infected patients showed 1.5 times the medical cost and 4.5 times the respiratory disease cost of the control group. People diagnosed with NTM infection incurred the highest medical costs in the 6 months before diagnosis. CONCLUSION: NTM infection increases the economic burden on Korean adults. Appropriate diagnostic tests and treatment plans for NTM infections are needed to reduce the burden of the disease caused by such infection.


Subject(s)
Mycobacterium Infections, Nontuberculous , Adult , Male , Humans , Female , Cohort Studies , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium Infections, Nontuberculous/therapy , Republic of Korea/epidemiology , National Health Programs , Delivery of Health Care
2.
Int J Mol Sci ; 21(18)2020 Sep 16.
Article in English | MEDLINE | ID: mdl-32948001

ABSTRACT

Mycobacterium abscessus is a non-tuberculous mycobacterium notoriously known for causing severe, chronic infections. Treatment of these infections is challenging due to either intrinsic or acquired resistance of M. abscessus to multiple antibiotics. Despite prolonged poly-antimicrobial therapy, treatment of M. abscessus infections often fails, leading to progressive morbidity and eventual mortality. Great research efforts are invested in finding new therapeutic options for M. abscessus. Clofazimine and rifabutin are known anti-mycobacterial antibiotics, repurposed for use against M. abscessus. Novel antimicrobials active against M. abscessus include delamanid, pretomanid and PIPD1 and the recently approved beta-lactamase inhibitors avibactam, relebactam and vaborbactam. Previously unused antimicrobial combinations, e.g. vancomycin-clarithromycin and dual beta-lactam therapy, have been shown to have synergistic effect against M. abscessus in experimental models, suggesting their possible use in multiple-drug regimens. Finally, engineered phage therapy has been reported to be clinically successful in a severe case of disseminated M. abscessus infection. While many of these experimental therapeutics have shown activity against M. abscessus in vitro, as well as in intracellular and/or animal models, most have little if any evidence of effect in human infections. Clinical studies of M. abscesssus treatments are needed to reliably determine the value of their incorporation in therapeutic regimens.


Subject(s)
Mycobacterium Infections, Nontuberculous/therapy , Mycobacterium abscessus/drug effects , Therapies, Investigational , Administration, Inhalation , Animals , Anti-Bacterial Agents/therapeutic use , Clinical Trials as Topic , Drug Evaluation, Preclinical , Drugs, Investigational/therapeutic use , Humans , Mice , Mycobacterium Infections, Nontuberculous/drug therapy , Nitric Oxide/administration & dosage , Nitric Oxide/therapeutic use , Phage Therapy , Zebrafish
4.
Dermatol Surg ; 46(1): 116-121, 2020 01.
Article in English | MEDLINE | ID: mdl-30964788

ABSTRACT

BACKGROUND: Nontuberculous mycobacterium (NTM) infection following cosmetic procedures usually results from inadequate sterile techniques and contamination from nonsterile water. These infections are difficult to diagnose and treat. OBJECTIVE: This study aimed to describe the characteristics of NTM infections acquired after an aesthetic procedure, identify high-risk patients and high-risk cosmetic procedures, and provide a diagnostic and management algorithm for NTM infections occurring after cosmetic procedures. METHODS: On December 20, 2017 an online search of the Medline database was done. All articles describing NTM infection in cosmetic procedures were included in this review. RESULTS: In total, 92 patients with a mean age of 38.35 years were included in this review. Cosmetic procedures performed in the Dominican Republic were the most common source of infection and were noted in 33 patients. The procedure that resulted in the highest proportion of the infections was mesotherapy (34%). In most of the cases, the diagnosis was missed at the initial presentation and a short course of inadequate antibiotics was unsuccessful. CONCLUSION: Nontuberculous mycobacterium infections are hard to diagnose and difficult to treat, sometimes leading to severe irreversible sequalae. Aesthetic practitioners should know when to suspect and how to prevent, diagnose, and treat NTM infections.


Subject(s)
Algorithms , Cosmetic Techniques/adverse effects , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/therapy , Humans , Mycobacterium Infections, Nontuberculous/etiology
7.
BMJ Case Rep ; 20172017 Jan 30.
Article in English | MEDLINE | ID: mdl-28137898

ABSTRACT

A 66-year-old multimorbid man with rheumatoid arthritis developed an infection after a steroid injection in the hand. Mycobacterium chelonae was cultured 1-month after presentation. In the mean time, his third finger had been amputated. Further treatment was based on preliminary susceptibility testing and the American Thoracic Society guidelines. No regression of the infection was observed before the addition of linezolid (600 mg×1/day) to a combination antimicrobial therapy also consisting of clarithromycin (500 mg×2/day) and moxifloxacin (400 mg×1/day), even though two methods of susceptibility testing, the E-test and broth microdilution, had shown susceptibility to other antimicrobial drugs. The healing was complete 12 months after presentation. There were no serious side effects observed with the use of linezolid in reduced dosage of 600 mg×1/day for a duration of 9 months.


Subject(s)
Amputation, Surgical , Anti-Bacterial Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Injections, Intra-Articular/adverse effects , Injections/adverse effects , Mycobacterium Infections, Nontuberculous/therapy , Tenosynovitis/therapy , Adrenal Cortex Hormones/therapeutic use , Aged , Clarithromycin/therapeutic use , Drug Therapy, Combination , Fluoroquinolones/therapeutic use , Hand , Humans , Linezolid/therapeutic use , Male , Microbial Sensitivity Tests , Moxifloxacin , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium chelonae
8.
Respiration ; 92(5): 316-328, 2016.
Article in English | MEDLINE | ID: mdl-27728916

ABSTRACT

BACKGROUND: The poor treatment outcomes of multidrug-resistant tuberculosis (TB) and the emergence of extensively drug-resistant TB and extremely and totally drug-resistant TB highlight the urgent need for new antituberculous drugs and other adjuvant treatment approaches. OBJECTIVES: We have treated cavitary tuberculosis by the application of endobronchial one-way valves (Zephyr®; Pulmonx Inc., Redwood City, Calif., USA) to induce lobar volume reduction as an adjunct to drug treatment. This report describes the feasibility, effectiveness and safety of the procedure. METHODS: Patients with severe lung destruction, one or more cavities or those who were ineligible for surgical resection and showed an unsatisfactory response to standard drug treatments were enrolled. During bronchoscopy, endobronchial valves were implanted in the lobar or segmental bronchi in order to induce atelectasis and reduce the cavity size. RESULTS: Four TB patients and 1 patient with atypical mycobacteriosis were treated. The mean patient age was 52.6 years. Complete cavity collapses were observed on CT scans in 4 of the 5 cases. All patients showed improvements in their clinical status, and sputum smears became negative within 3-5 months. There were no severe short- or long-term complications. The valves were removed in 3 of the 5 patients after 8 months on average; there was no relapse after 15 months of follow-up. CONCLUSION: These data suggest that endobronchial valves are likely to be useful adjuncts to the treatment of therapeutically difficult patients. More data are required to confirm our findings.


Subject(s)
Antitubercular Agents/therapeutic use , Bronchoscopy/methods , Collapse Therapy/methods , Mycobacterium Infections, Nontuberculous/therapy , Prosthesis Implantation/methods , Tuberculosis, Multidrug-Resistant/therapy , Tuberculosis, Pulmonary/therapy , Adult , Aged , Collapse Therapy/history , Combined Modality Therapy , Feasibility Studies , Female , History, 19th Century , History, 20th Century , Humans , Male , Middle Aged , Pneumothorax, Artificial/history , Pneumothorax, Artificial/methods , Treatment Outcome , Tuberculosis, Pulmonary/history
12.
Ann Dermatol Venereol ; 135(8-9): 591-5, 2008.
Article in French | MEDLINE | ID: mdl-18789296

ABSTRACT

INTRODUCTION: Cutaneous infections due to Mycobacterium fortuitum, a rapidly growing environmental mycobacteria, are often iatrogenic, resulting from surgery or injection. We report two cases following plastic surgery and describe the outcome after surgery and antibiotics. CASE REPORTS: Two immunocompetent women underwent abdominal plastic surgery and liposuction, which were complicated with recurrent abscesses one and 13 months later respectively. Cultures of bacteriologic samples isolated M. fortuitum in the two patients. The two strains exhibited different antibiotic sensibility profiles. The initial antibiotic therapy consisted of combined amikacin and moxifloxacin in both patients plus imipenem in one, followed by oral doxycycline and clarithromycin in one and moxifloxacin in the other for a total duration of nine and five months, respectively. In both cases, surgical treatment was also given before, during and after antibiotic therapy. No new lesions had appeared six months after the end of antibiotic therapy. DISCUSSION: Cutaneous infections due to M. fortuitum are rare and secondary to iatrogenic skin wounds. The clinical appearance is not specific, accounting for delayed diagnosis. Treatment is difficult and there is no consensus. According to our experience, surgical treatment is essential whereas the efficacy of antibiotics, even involving multiple agents, seems more doubtful.


Subject(s)
Abdominal Wall/surgery , Lipectomy/adverse effects , Mycobacterium Infections, Nontuberculous/therapy , Mycobacterium fortuitum , Postoperative Complications/therapy , Skin Diseases, Bacterial/therapy , Surgery, Plastic/adverse effects , Administration, Oral , Adult , Amikacin/administration & dosage , Amikacin/therapeutic use , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Aza Compounds/administration & dosage , Aza Compounds/therapeutic use , Clarithromycin/administration & dosage , Clarithromycin/therapeutic use , Doxycycline/administration & dosage , Doxycycline/therapeutic use , Drug Therapy, Combination , Female , Fluoroquinolones , Follow-Up Studies , Humans , Imipenem/administration & dosage , Imipenem/therapeutic use , Middle Aged , Moxifloxacin , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium Infections, Nontuberculous/surgery , Mycobacterium fortuitum/isolation & purification , Postoperative Complications/drug therapy , Postoperative Complications/etiology , Postoperative Complications/surgery , Quinolines/administration & dosage , Quinolines/therapeutic use , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/etiology , Skin Diseases, Bacterial/surgery , Time Factors , Treatment Outcome
13.
Trop Med Int Health ; 12(3): 445-58, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17313516

ABSTRACT

Buruli ulcer disease (BUD), a devastating tropical disease caused by Mycobacterium ulcerans, occurs in more than 80% of the administrative districts of Ghana. To elucidate community perceptions and understanding of the aetiology of BUD, attitudes towards Buruli patients and treatment-seeking behaviours, we conducted a survey with 504 heads of households and seven focus group discussions in Ga West District, Ghana. Although 67% of participants regarded BUD as a health problem, 53% did not know its cause. Sixteen per cent attributed the cause to drinking non-potable water, 8.1% mentioned poor personal hygiene or dirty surroundings, and 5.5% identified swimming or wading in ponds as a risk factor. About 5.2% thought that witchcraft and curses cause BUD, and 71.8% indicated that BU sufferers first seek treatment from herbalists and only refer to the hospital as a last resort. The main reasons were prospects of prolonged hospital stay, cost of transport, loss of earnings and opportunity associated with parents attending their children's hospitalization over extended period, delays in being attended by medical staff, and not knowing the cause of the disease or required treatment. The level of acceptance of BUD sufferers was high in adults but less so in children. The challenge facing health workers is to break the vicious cycle of poor medical outcomes leading to poor attitudes to hospital treatment in the community. Because herbalists are often the first people consulted by those who contract the disease, they need to be trained in early recognition of the pre-ulcerative stage of Buruli lesions.


Subject(s)
Health Knowledge, Attitudes, Practice , Mycobacterium Infections, Nontuberculous/transmission , Mycobacterium ulcerans , Skin Diseases, Bacterial/transmission , Adult , Age Distribution , Child , Cross-Sectional Studies , Female , Focus Groups , Ghana/epidemiology , Humans , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/prevention & control , Mycobacterium Infections, Nontuberculous/therapy , Patient Acceptance of Health Care , Population Surveillance/methods , Prevalence , Risk Factors , Rural Health , Sex Distribution , Skin Diseases, Bacterial/prevention & control , Skin Diseases, Bacterial/therapy , Social Perception , Witchcraft
16.
Clin Infect Dis ; 37(6): e78-82, 2003 Sep 15.
Article in English | MEDLINE | ID: mdl-12955667

ABSTRACT

We studied a 4-year-old boy from Angola who presented with 2 cutaneous ulcerations of the right hip and osteomyelitis of the left knee and right ankle. Mycobacterium ulcerans disease was confirmed by direct smear examination and by polymerase chain reaction. The patient was treated with antimycobacterial drugs, repeated surgical debridement, skin grafting, and daily hyperbaric oxygenation. Despite significant improvement of the local lesions in response to hyperbaric oxygenation, swelling of the right knee, without associated skin lesions, was noted. Radiological evaluation and open biopsy revealed extensive metaphyseal osteomyelitis of the right distal femur. A 99technetium bone scan revealed an additional focus in the diaphysis of the left humerus, without soft-tissue involvement. This case documents, for the first time (to our knowledge), the systemic spread of M. ulcerans, with subsequent multifocal osteomyelitis and secondary involvement of soft tissues and supports the hypothesis that low tissue oxygen levels promote hematogenous spread of M. ulcerans. Sickle cell anemia, with associated microthrombosis and microinfarction, may have contributed to tissue hypoxia.


Subject(s)
Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium ulcerans , Osteomyelitis/microbiology , Skin Diseases, Bacterial/diagnosis , Antitubercular Agents/therapeutic use , Child, Preschool , Humans , Hyperbaric Oxygenation/methods , Male , Mycobacterium Infections, Nontuberculous/therapy , Osteomyelitis/etiology , Skin Diseases, Bacterial/therapy
17.
J Med Assoc Thai ; 86(8): 772-80, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12948277

ABSTRACT

OBJECTIVES: A series of cases infected with rapidly growing mycobacteria were studied to reveal the spectrum of disease, antimicrobial susceptibility, pathology, and treatment outcomes. METHOD: The cases identified as rapidly growing mycobacterial infections in Ramathibodi Hospital from January 1993 to June 1999 were retrospectively studied. RESULTS: There were 20 patients and most of the cases had no underlying disease. Only two cases were HIV-infected patients. The presenting clinical features were lymphadenitis (7), skin and subcutaneous abscess (7), eye infection (4), pulmonary infection (1), and chronic otitis media (1). Four of the seven cases with lymphadenitis had Sweet's syndrome. The organisms were Mycobacterium chelonae/abscessus group (17 cases) and Mycobacteriumfortuitum group (3 cases). The organisms were susceptible to amikacin, netilmicin and imipenem. The M. fortuitum group was susceptible to more antibiotics than the M. chelonaelabscessus group. Pathology of the infected tissue varied from non-specific findings to suppurative or caseous granuloma. The clinical responses corresponded to the antimicrobial susceptibility. Most of the patients had a good clinical outcome. A combination of two or more drugs was used for the medical treatment. Surgical resection was performed where possible to reduce the load of the organism, especially in cases with very resistant organisms. CONCLUSIONS: Rapidly growing mycobacterial infections can occur in apparently normal hosts. Clinical syndrome is variable. The pathology is non-specific and culture is needed for definite diagnosis. Clinical responses varied but seemed to correlate with the in vitro susceptibility result. More studies are needed before one can deal with these infections more effectively.


Subject(s)
Drug Therapy, Combination/therapeutic use , Mycobacterium chelonae , Mycobacterium fortuitum , Adolescent , Adult , Aged , Anti-Bacterial Agents/pharmacology , Drainage , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/therapy , Mycobacterium chelonae/drug effects , Mycobacterium fortuitum/drug effects , Retrospective Studies , Treatment Outcome
18.
Trop Med Int Health ; 8(8): 750-9, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12869098

ABSTRACT

We investigated cultural beliefs and psychosocial factors associated with Buruli ulcer in southern Benin in order to elaborate and deliver appropriate health education messages. We conducted a qualitative study among 130 adults and 30 children in Zou province, a highly endemic region. Focus group interviews of inhabitants, patients and their assistants, health care professionals and traditional healers took place in Dasso, Ouinhi, Sagon and Zagnanado. Drawing sessions followed by individual interviews were organized among school children in Dasso and Sagon. We found that although Buruli ulcer is well known and recognized - even at a very early stage of the disease - and perceived as threatening, most people are reluctant to seek treatment at the health care centre. They are unclear about the origin of the disease (environmental factors or sorcery) and treatment is considered devastating, expensive and ineffective in some cases.


Subject(s)
Mycobacterium Infections, Nontuberculous/psychology , Mycobacterium ulcerans , Patient Acceptance of Health Care , Skin Ulcer/psychology , Adolescent , Adult , Age Factors , Aged , Benin , Child , Communication , Culture , Female , Focus Groups , Health Education , Humans , Male , Medicine, African Traditional , Middle Aged , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium Infections, Nontuberculous/therapy , Skin Ulcer/microbiology , Skin Ulcer/therapy
19.
J Dermatol ; 29(12): 810-1, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12532049

ABSTRACT

We report a case of atypical mycobacterial dermal infection caused by M. marinum, which was effectively treated with oral administration of minocycline and local hyperthermic treatment using chemical pocket warmers. A daily oral dose of 200 mg of minocycline was given, and local hyperthermic treatment was applied every evening for 5-6 hours with a disposable chemical pocket warmer. After 2.5 months of therapy, the lesion healed completely with scar formation. At 24 months after the completion of treatments, there is no sign of recurrence.


Subject(s)
Hyperthermia, Induced/methods , Minocycline/administration & dosage , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/therapy , Nontuberculous Mycobacteria/isolation & purification , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/therapy , Administration, Oral , Adult , Combined Modality Therapy , Drug Administration Schedule , Follow-Up Studies , Humans , Male , Treatment Outcome
20.
Hautarzt ; 47(11): 863-6, 1996 Nov.
Article in German | MEDLINE | ID: mdl-9036143

ABSTRACT

A 70-year-old patient developed Mycobacterium chelonae infection at a donor vein graft site following cardiac bypass surgery. The infection presented as fibrinous, necrotic ulcerations in the scar area. Mycobacterium chelonae and mycobacterium fortuitum are atypical mycobacteria and have been described previously causing infections after injections or surgical procedures. Infection of donor vein graft site is a rare complication after cardiac surgery. As mycobacterium chelonae cannot be cultivated on normal culture media, delayed wound healing might be disinterpretated as a primary wound healing disorder. Treatment of atypical myobacteriosis includes antibiotics, local heat therapy and surgical excision. Clarithromycin is the antibiotic of choice. We obtained complete healing after two months of Clarithromycin treatment, combined with heat therapy.


Subject(s)
Coronary Artery Bypass , Cross Infection/diagnosis , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium chelonae , Saphenous Vein/transplantation , Surgical Wound Infection/diagnosis , Aged , Clarithromycin/administration & dosage , Combined Modality Therapy , Cross Infection/therapy , Humans , Infrared Rays/therapeutic use , Male , Mycobacterium Infections, Nontuberculous/therapy , Surgical Wound Infection/therapy
SELECTION OF CITATIONS
SEARCH DETAIL